Patents for C07D - Heterocyclic compounds (10,420) |
---|
01/03/2001 | EP1064967A2 5HT1 receptor agonists, caffeine and either a COX-2 inhibitor or NSAID for the treatment of migraine |
01/03/2001 | EP1064966A2 Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine |
01/03/2001 | EP1064948A2 Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine |
01/03/2001 | EP1064284A1 Hypnotic beta-carboline derivatives, process for their preparation and their use as medicinal products |
01/03/2001 | CN1278822A 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
01/03/2001 | CN1278722A 8a-azalides as veterinary antimicrobial agents for animals |
01/02/2001 | US6169181 Compounds useful to treat retroviral infections |
01/02/2001 | CA1341164C 1-hydroxyethyl-azole derivatives, a process for their preparation and their use as plant growth regulators and fungicides |
12/30/2000 | CA2312989A1 Combination therapy for the treatment of migraine |
12/30/2000 | CA2312633A1 Combination therapy for the treatment of migraine |
12/30/2000 | CA2312631A1 5ht1 receptor agonists, caffeine and either a cox-2 inhibitor or nsaid for the treatment of migraine |
12/28/2000 | WO2000078759A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
12/28/2000 | CA2375265A1 Polymorphs of crystalline azo-bicyclo 2,2,2,oct-3-yl amine dihydrochloride and their pharmaceutical compositions |
12/27/2000 | EP1062217A1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
12/27/2000 | EP1062214A1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels |
12/27/2000 | EP1062201A2 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
12/27/2000 | EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
12/27/2000 | CN1278178A Use of macrolies for treating cancer and macular degeneration |
12/27/2000 | CN1278172A Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function |
12/27/2000 | CN1059902C Estrogen excitant/antagonist |
12/27/2000 | CN1059901C Preparation of arthropodicidal oxadiazines |
12/26/2000 | US6166027 Treatment of high blood pressure and cardiac insufficiency, angina pectoris, arrhythmias, thromboembolic diseases, ischaemias, myocardial infarction, cerebral stroke, restenoses, coronary angioplasties, arteriosclerosis |
12/26/2000 | US6166025 A stable, aqueous drug formulation for treating migraine |
12/21/2000 | WO2000077000A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
12/21/2000 | WO2000076999A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
12/21/2000 | WO2000076998A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
12/21/2000 | WO2000076997A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
12/21/2000 | WO2000076961A1 Inhibitors of aspartyl protease |
12/21/2000 | CA2384339A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
12/21/2000 | CA2377395A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
12/21/2000 | CA2377325A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
12/21/2000 | CA2375841A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
12/20/2000 | CN1277605A Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors |
12/14/2000 | WO2000075139A2 Benzothiazinone and benzoxazinone compounds |
12/14/2000 | CA2375734A1 Benzothiazinone and benzoxazinone compounds |
12/13/2000 | CN1276790A Carboxamidothiazole derivs., preparation, pharmaceutical composition contg. them |
12/13/2000 | CN1276370A Process for preparing anticancer compound, and intermediate |
12/12/2000 | US6160123 One pot synthesis of 2-oxazolidinone derivatives |
12/07/2000 | WO2000073303A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists |
12/07/2000 | WO2000073298A1 Mutual prodrugs of amlodipine and atorvastatin |
12/07/2000 | WO2000037141A9 Combination chemotherapy |
12/07/2000 | CA2372236A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo¬2,2,2|oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists |
12/06/2000 | EP1056759A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
12/05/2000 | US6156889 Reagent useful for cleaving a protected functional group |
11/30/2000 | WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
11/30/2000 | WO2000071122A1 Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process |
11/29/2000 | CN1275123A Prostaglandin agonists and their use to treat bone disorders |
11/29/2000 | CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives |
11/29/2000 | CN1058841C Fungicidal oxazolidinones |
11/28/2000 | US6153751 Preparing the antiviral b-isomer of a 1,3-oxathiolane nucleoside by reacting in presence of stannic chloride |
11/28/2000 | US6153624 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders |
11/28/2000 | US6153622 Estrogen agonists/antagonists |
11/23/2000 | WO2000069862A2 Hemisynthetic method and intermediates thereof |
11/22/2000 | EP1052974A2 Compositions containing organic compounds |
11/22/2000 | EP1052973A1 Transmucosal formulations of levosimendan |
11/22/2000 | CN1273974A Camptothecin derviative, its prepn. method and medicinal compsns. containing same |
11/22/2000 | CN1058709C Amide compounds for medical treatment |
11/21/2000 | US6150530 Amidation of amine with acid |
11/21/2000 | US6150393 N-(3-(4-bromo-1-methylpyrazol-3-yl)phenyl)(phenylmethylamino) -carboxamide modifier of activity of the serotonin 5-ht 2a; cns, gastrointestinal and cardiovascular disorders; antiinflammatory agents; side effect reduction |
11/21/2000 | US6150380 Crystalline form of omeprazole |
11/21/2000 | CA2083639C Substituted phenyl phenol leukotriene antagonists |
11/21/2000 | CA2016513C Process for 3-exomethylenecepham sulfoxide esters |
11/21/2000 | CA2010085C Pentamidine solutions |
11/15/2000 | EP1052255A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics. |
11/15/2000 | EP1051425A2 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES |
11/14/2000 | US6147104 Used in combating parasitic fungus |
11/14/2000 | CA2080221C An improved process for the preparation of substituted indolone derivatives |
11/09/2000 | WO2000066584A1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
11/09/2000 | WO2000066556A1 Indoline derivatives as progesterone antagonists |
11/09/2000 | WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
11/09/2000 | CA2388658A1 1-amino triazolo[4,3-a]quinazolin-5-ones and or -5-thiones inhibiting phosphodiesterase iv |
11/09/2000 | CA2371638A1 Indoline derivatives as progesterone antagonists |
11/08/2000 | EP1049695A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
11/08/2000 | EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound |
11/08/2000 | CN1272845A Process for preparation of oxymorphone, oxycodone and derivatives |
11/07/2000 | US6143771 Benzimidazole derivative drugs |
11/07/2000 | US6143744 Sulfamide-metalloprotease inhibitors |
11/07/2000 | CA2080223C Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
11/02/2000 | WO2000033878A3 Stabilization of macrolides |
11/02/2000 | EP1048647A1 N-Chlorocarbonyl-carbamate derivative and its use in the preparation of arthropodicidal oxadiazines |
11/02/2000 | EP1047668A1 Triazepinones, process for their preparation and their therapeutic application |
11/01/2000 | CN1272109A Process for producing isooxazolidinedione compound |
11/01/2000 | CN1058011C 13-substituted milbemycin derivatives, and their use |
10/31/2000 | US6140343 Cholesteryl ester transfer protein inhibitors which are used to elevate highdensity lipoprotein-cholesterol and to lower low density lipoprotein-cholesterol and triglycerides; for treating atherosclerosis, peripheral vascular disease, obesity |
10/25/2000 | CN1270960A Process for preparing growth hormone cinogenic agent |
10/25/2000 | CN1270959A 4-phenyl pyridine derivatives |
10/25/2000 | CN1270958A Beta-lactan |
10/24/2000 | US6136809 Azolo triazines and pyrimidines |
10/24/2000 | US6136242 Providing pressure cell with single or multi-channel die for strand formation; filling pressure cell with cyanuric chloride melt; cooling wall of pressure cell and die; pressing solidified cyanuric chloride out of die; reducing size |
10/19/2000 | WO2000061122A2 Use of 6-methylmercaptopurine riboside in ophthalmologic compositions |
10/18/2000 | EP1044969A2 Processes and intermediates for preparing anti-cancer compounds |
10/18/2000 | CN1270592A Spiroazabicyclic heterocyclic compounds |
10/17/2000 | US6132774 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone |
10/17/2000 | CA2006719C Antibacterial antiplaque oral composition |
10/12/2000 | CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
10/11/2000 | EP1042321A1 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use |
10/11/2000 | CN1269800A Tetrahydro Gamma-carbolines |
10/11/2000 | CN1269790A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments |
10/05/2000 | WO2000058305A1 Novel compounds |
10/05/2000 | WO2000058293A2 Glucokinase activators |